The total return over the past 12 months is +134.52% vs. +16.94% for the S&P 500. So far it's up +8.31% this year. Includes price appreciation + reinvested dividends.
| Category | 1Y (TTM) | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Price CAGR | +134.52% | (27.90%) | (22.82%) | (13.70%) | (6.98%) | N/A |
| Total Return CAGR | +134.52% | (27.90%) | (22.82%) | (13.70%) | (6.98%) | N/A |
| Revenue CAGR | +26.19% | (3.05%) | (1.18%) | +6.20% | +15.08% | N/A |
| Net Income CAGR | N/A | N/A | (23.90%) | N/A | N/A | N/A |
| EPS CAGR | N/A | N/A | (25.87%) | N/A | N/A | N/A |
| Free Cash Flow CAGR | +519.83% | (11.01%) | (3.98%) | N/A | N/A | N/A |
| Operating Cash Flow CAGR | +518.83% | (11.02%) | (3.99%) | N/A | N/A | N/A |
| Dividends CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.
Ironwood Pharmaceuticals, Inc. (IRWD)
| Year | Start price | End price | IRWD Return | SPY Return | Outperformance |
|---|---|---|---|---|---|
| 2026(YTD) | $3.37 | $3.65 | +8.31% | +14.51% | (6.20%) |
| 2025 | $4.43 | $3.37 | (23.93%) | +17.72% | (41.65%) |
| 2024 | $11.44 | $4.43 | (61.28%) | +24.89% | (86.17%) |
| 2023 | $12.39 | $11.44 | (7.67%) | +26.19% | (33.86%) |
| 2022 | $11.66 | $12.39 | +6.26% | (18.17%) | +24.43% |
| 2021 | $11.39 | $11.66 | +2.37% | +28.74% | (26.37%) |
| 2020 | $13.31 | $11.39 | (14.43%) | +18.37% | (32.80%) |
| 2019 | $10.36 | $13.31 | +28.47% | +31.22% | (2.75%) |
| 2018 | $14.99 | $10.36 | (30.89%) | (4.56%) | (26.33%) |
| 2017 | $15.29 | $14.99 | (1.96%) | +21.70% | (23.66%) |
Start and end prices are split-adjusted closing prices. Total return includes reinvested dividends, so it can differ from the price change.
